Essay Sample: Safety Concerns for a New Forensic Nurse of a Trauma Patient

The diagnosis that can benefit from an evidence-based practice is heart failure. Heart failure is a condition that occurs when the heart muscles are unable to pump blood well to the body as required. The condition is caused by other conditions such as high blood pressure or coronary heart disease (narrowed arteries in the heart) that make the heart muscles weak to pump blood properly. Heart failure may progress in four phases A, B, C, and D (Rossignol et al., 2019). The condition can lead to death if not well-managed. Therefore, effective clinical care is recommended using evidence-based practice to enhance the quality and promote management of the condition.

Is your time best spent reading someone else’s essay? Get a 100% original essay FROM A CERTIFIED WRITER!

Save 25%

Evidence-based practice (EBP) is the conscientious application of contemporary best evidence to make decisions in caring for a patient. The EBP provides numerous benefits for quality healthcare for patients with a heart failure condition. The following are some of the benefits of using EBP in providing health care for patients with heart failure. The evidence-based practice enhances the patient's outcomes (Rossignol et al., 2019). It is based on the proper treatment methods that have been tested in other patients over time, and the results are gauged and judged to be effective (Greene et al., 2019).

The methods in evidence-based practice are justified by research results that are consistent and effective. It is believed that the method of treatment that has worked for some patients under study can as well work in other patients with similar conditions (Greene et al., 2018). Therefore, evidence-based practice is the most effective way of managing health conditions such as heart failure based on the results and evidence from other similar conditions in past research. In addition, the evidence-based practice reduces costs of care by using patient-centered approaches to manage health conditions. Many patient-centered approaches manage the patient’s lifestyle factors that may increase the chances of developing heart failure symptoms (Greene et al., 2019). Treatment based on the patient's holistic view can be effective in providing some measures that eliminate the predisposing factors to heart failure.

Credible resources are essential to inform the decision for evidence-based practice. Evaluating the credibility of resources requires an assessment of five main criteria to the potential sources such as authority, accuracy, currency, relevance, and objectivity. The information resource's authority is the measure of knowledge, experience, interest, and integrity of the content creator. Accuracy of a resource concerns the verifiability and quality of its content. Current resources are recommended because they capture the most recent developments in the field of research, thereby providing up-to-date information for knowledge and practice.

The objectivity of a resource concerns the author's biases, publisher, or sponsor of the research. The chosen resource should also be relevant by fitting the argument being considered well (Reddy et al., 2018). Choosing a credible information resource should follow these criteria to inform better judgment and decision in the following way. The resource should satisfy all the five criteria such that its author or authors have relevant knowledge and experience in the field of the study, the information provided is verifiable, provides up-to-date information on the most recent developments, and the information provided fits well the argument for which it is considered.

The resources used in this research include the “Contemporary Drug Treatment of Chronic Heart Failure with Reduced Ejection Fraction” by Brunner-La Rocca et al. (2019), “Medical Therapy for Heart Failure with Reduced Ejection Fraction” by Greene et al. (2018), “Titration of Medical Therapy for Heart Failure with Reduced Ejection Fraction” by Greene et al. (2019), “A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure with Preserved Ejection Fraction” by Reddy et al. (2018), and “Heart Failure Drug Treatment” by Rossignol et al. (2019). The authors of these articles are researchers from the Department of Cardiology in various recognized universities and hospitals.

The contents of the articles are accurate because they are of high quality and verifiable. The resources are current and provide up-to-date information on evidence-based practice in caring for patients suffering from heart failure. The resources are relevant because they further the interest of this research. Greene et al. (2018) is the most important resource among them. The resource findings identified multiple clinical factors associated with prescribed dose and medication use for patients with a heart failure condition.

It is important to incorporate credible resources into an evidence-based practice model in addressing heart failure conditions. The evidence-based treatment could improve heart failure treatment by lowering mortality in heart failure and reducing the costs of treatment (Reddy et al., 2018). Therefore, evidence-based practice is paramount for enhancing treatment and care for patients with a heart failure condition.

References

Brunner-La Rocca, H. P., Linssen, G. C., Smeele, F. J., van Drimmelen, A. A., Schaafsma, H. J., Westendorp, P. H., ... & CHECK-HF Investigators. (2019). Contemporary drug treatment of chronic heart failure with reduced ejection fraction: the CHECK-HF registry. JACC: Heart Failure, 7(1), 13-21. https://heartfailure.onlinejacc.org/content/7/1/13.abstract

Greene, S. J., Butler, J., Albert, N. M., DeVore, A. D., Sharma, P. P., Duffy, C. I., ... & Spertus, J. A. (2018). Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. Journal of the American College of Cardiology, 72(4), 351-366. https://www.onlinejacc.org/content/72/4/351?_ga=2.91060442.1552013586.1533172651-1536918256.1519143499

Greene, S. J., Fonarow, G. C., DeVore, A. D., Sharma, P. P., Vaduganathan, M., Albert, N. M., ... & Spertus, J. A. (2019). Titration of medical therapy for heart failure with reduced ejection fraction. Journal of the American College of Cardiology, 73(19), 2365-2383. https://www.onlinejacc.org/content/73/19/2365.abstract

Reddy, Y. N., Carter, R. E., Obokata, M., Redfield, M. M., & Borlaug, B. A. (2018). A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation, 138(9), 861-870. https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.118.034646

Rossignol, P., Hernandez, A. F., Solomon, S. D., & Zannad, F. (2019). Heart failure drug treatment. The Lancet, 393(10175), 1034-1044. https://www.sciencedirect.com/science/article/abs/pii/S0140673618318087